alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet
RxNorm concept 1368410, clinical drug (scd).
- RxCUI
- 1368410
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1368410 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet
Related concepts
- pioglitazone 30 MG (SCDC, consists of)
- alogliptin 12.5 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet [Oseni] (SBD, has tradename)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1368410 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1368410 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1368410. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.